2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential...

23
Helping People. Its who we are and what we do. Steve Sisolak Richard Whitley, MS Governor Director Julie Kotchevar, PhD DPBH Administrator 2019 Essential Diabetes Drug List Report Date: February 1, 2019 Prepared by: Primary Care and Health Workforce Development Office, State of Nevada Division of Public and Behavioral Health (DPBH) 4150 Technology Way, Suite 300, Carson City, NV 89706 Office: (775) 684-4255 Email: [email protected] drugtransparency.nv.gov

Transcript of 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential...

Page 1: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Helping People. It’s who we are and what we do.

Steve Sisolak Richard Whitley, MS

Governor Director

Julie Kotchevar, PhD

DPBH Administrator

2019Essential Diabetes

Drug ListReport Date:

February 1, 2019

Prepared by: Primary Care and Health Workforce Development Office, State of Nevada

Division of Public and Behavioral Health (DPBH) 4150 Technology Way, Suite 300, Carson City, NV 89706

Office: (775) 684-4255 Email: [email protected] drugtransparency.nv.gov

Page 2: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Helping People. It’s who we are and what we do.

During the 79th legislative session, Senate Bill (SB) 539, which supports prescription drug transparency, was approved. SB 539 was codified in Nevada Revised Statutes (NRS) 439B. The law requires in NRS 439B.630 that the Department of Health and Hu-man Services (DHHS) compile a list of prescription drugs essential for treating diabetes in Ne-vada:

NRS 439B.630 Department to annually compile lists of certain prescription drugs essential for treating diabetes. On or before February 1 of each year, the De-partment shall compile:

1. A list of prescription drugs that the Department determines to be essential for treat-ing diabetes in this State and the wholesale acquisition cost of each such drug on thelist. The list must include, without limitation, all forms of insulin and biguanides mar-keted for sale in this State.

2. A list of prescription drugs described in subsection 1 that have been subject to anincrease in the wholesale acquisition cost of a percentage equal to or greater than:

a.) The percentage increase in the Consumer Price Index, Medical Care Compo-nent during the immediately preceding calendar year; or

b.) Twice the percentage increase in the Consumer Price Index, Medical Care Component during the immediately preceding 2 calendar years.

(Added to NRS by 2017, 4297)

The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug List identifies Nevada’s essential diabetes drugs as of the publication date and also indicates if these drugs underwent a significant price increase as defined by NRS 439B.630 (2). To produce the current list, DHHS posted a draft version of the essential diabetes drug list online on January 14, 2019 and received public and other stakeholder comments. All requests were carefully reviewed before finalization of this publication. Manufacturers that produce drugs found on this list are required to submit reports by April 1, 2019 that include information about these drugs as outlined in NRS 439B.635 and NRS 439B.640. Additionally, Pharmacy Benefit Managers (PBMs) are required to provide information to DHHS by April 1, 2019 regard-ing these drugs as outlined in NRS 439B.645. Data from these reports will be aggregated and published in the DHHS report required by NRS 439B.650 by June 1, 2019.

2

Introduction

Report Methodology

To compile the 2019 DHHS Essential Diabetes Drug list, DHHS utilized a methodology that met the requirements of NRS 439B.630. Two versions of the list are published: (1) a summary of the nonproprietary and brand or proprietary drug names found on the essential list [Appendix 1], and (2) a detailed list of all the National Drug Codes (NDCs) indicated by DHHS as essential dia-betes drugs and if each drug NDC experienced a significant price increase [Appendix 2]. The summary list [Appendix 1] provides a concise outline of the essential drugs, while the NDC list [Appendix 2] identifies the specific drug NDCs that will be monitored by DHHS and included in the yearly report.

Page 3: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Helping People. It’s who we are and what we do.

3

To generate the final list, DHHS compiled an initial list of diabetes drug NDCs that in-cluded varying drug packing formulations based on prior and current stakeholder input of essential diabetes drugs. These NDC codes were filtered down to include the drugs for which Nevada Medicaid expended funds in 2017 and/or 2018. Additional NDCs that were of interest to the public and stakeholders were added to this list.

This essential list does not include any drugs used to treat co-morbidities often present in indi-viduals with diabetes. The list does not contain every single drug that may be an effective treat-ment for diabetes or approved for the treatment of diabetes. This list attempts to refine the nu-merous treatments to those approved for treatment, identified by prescribers as essential, and most frequently prescribed in Nevada (as determined by publicly available data sources). For this reason, some brand names are excluded while generics or alternative brands are included.

DHHS welcomes feedback regarding this report. DHHS strives to ensure that consumers receive accurate information. Any identified errors, omissions, or feedback can be submitted to the de-partment via email at [email protected].

DHHS invites you to view the Drug Transparency website at drugtransparency.nv.gov. If you are interested in receiving email notifications for Nevada Drug Transparency information and up-dates, please subscribe online at http://drugtransparency.nv.gov to the DHHS Drug Transparen-cy LISTSERV.

Page 4: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Helping People. It’s who we are and what we do.

4

Appendix 1:

2019 DHHS Essential Diabetes Drug

Summary List

Page 5: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Page 1 of 2

5

Appendix 1: 2019 DHHS Essential Diabetes Drug Summary List

Essential Non-Propietary Drug NameIncluded Essential Drug Brand Names

(Note: some brand names are excluded from this list)

AcarboseAlbiglutide TanzeumAlogliptin NesinaAlogliptin and Metformin HCL KazanoAlogliptin and Pioglitazone OseniBromocriptine Mesylate CyclosetCanagliflozin InvokanaCanagliflozin and Metformin HCL Invokamet; Invokamet XRColesevelam HCL WelcholDapagliflozin FarxigaDapagliflozin and Metformin HCL Xigduo XRDulaglutide TrulicityEmpagliflozin JardianceEmpagliflozin and Linagliptin GlyxambiEmpagliflozin and Metformin HCL Synjardy; Synjardy XRErtugliflozin SteglatroErtugliflozin and Metformin HCL SeglurometErtugliflozin and Sitagliptin SteglujanExenatide Bydureon; Bydureon BCise; ByettaGlimepiride AmarylGlipizide Glucotrol; Glucotrol XL; Glipizide XL; Glipizide ERGlipizide and Metformin HCLGlucagon GlucaGenGlyburide GlynaseGlyburide and Metformin HCLInsulin Aspart Fiasp; Novolog; Novolog 70/30Insulin Degludec TresibaInsulin Degludec and Liraglutide Xultophy 100/3.6Insulin Detemir LevemirInsulin Glargine Basaglar; Lantus; ToujeoInsulin Glargine and Lixisenatide Soliqua 100/33Insulin Glulisine Apidra

Insulin HumanAfrezza; Humulin N; Humulin R; Humulin R500; Humulin 70/30; Novolin R; Novolin N; Novolin 70/30

Insulin LisproAdmelog; Humalog; Humalog 50-50; Humalog 75-25; Humalog Jr

Linagliptin TradjentaLinagliptin and Metformin HCL Jentadueto; Jentadueto XRLiraglutide VictozaLixisenatide Adlyxin

Metformin HCLFortamet ER; Glumetza ER; Glucophage; Glucophage XR; Riomet; Metformin ER

Miglitol Glyset

Page 6: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 1: 2019 DHHS Essential Diabetes Drug Summary ListPage 2 of 2

6

Essential Non-Propietary Drug NameIncluded Essential Drug Brand Names

(Note: some brand names are excluded from this list)

Nateglinide StarlixPioglitazone ActosPioglitazone and GlimepiridePioglitazone and Metformin HCL Actoplus Met; Actoplus Met XRPramlintide Acetate SymlinPenRepaglinide PrandinRosiglitazone AvandiaSaxagliptin OnglyzaSaxagliptin and Metformin HCL Kombiglyze XRSemaglutide OzempicSitagliptin JanuviaSitagliptin and Metformin HCL Janumet; Janumet XR

Page 7: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Helping People. It’s who we are and what we do.

7

Appendix 2:

2019 Essential Diabetes Drug

NDC List

Page 8: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Page 1 of 16

8

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC List

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

16252-0523-01 Acarbose Actavis Pharma, Inc.47781-0340-01 Acarbose Alvogen, Inc.47781-0341-01 Acarbose Alvogen, Inc.47781-0342-01 Acarbose Alvogen, Inc.00115-1152-02 Acarbose Global Pharmaceuticals23155-0149-01 Acarbose Heritage Pharmaceuticals Inc.00378-2821-77 Acarbose Mylan64380-0758-06 Acarbose Strides Shasun Limited64380-0759-06 Acarbose Strides Shasun Limited64380-0760-06 Acarbose Strides Shasun Limited69543-0120-10 Acarbose Virtus Pharmaceuticals LLC69543-0121-10 Acarbose Virtus Pharmaceuticals LLC69543-0122-10 Acarbose Virtus Pharmaceuticals LLC00054-0140-25 Acarbose West-Ward Pharmaceuticals Corp00054-0141-25 Acarbose West-Ward Pharmaceuticals Corp00054-0142-25 Acarbose West-Ward Pharmaceuticals Corp64764-0158-60 Actoplus Met Takeda Pharmaceuticals U.S.A., Inc.64764-0310-30 Actoplus Met XR Takeda Pharmaceuticals U.S.A., Inc.64764-0510-30 Actoplus Met XR Takeda Pharmaceuticals U.S.A., Inc.64764-0151-04 Actos Takeda Pharmaceuticals U.S.A., Inc.64764-0151-05 Actos Takeda Pharmaceuticals U.S.A., Inc.64764-0301-14 Actos Takeda Pharmaceuticals U.S.A., Inc.64764-0301-15 Actos Takeda Pharmaceuticals U.S.A., Inc.64764-0451-24 Actos Takeda Pharmaceuticals U.S.A., Inc.64764-0451-25 Actos Takeda Pharmaceuticals U.S.A., Inc.00024-5745-02 Adlyxin Sanofi-Aventis U.S. LLC Yes00024-5747-02 Adlyxin Sanofi-Aventis U.S. LLC Yes00024-5924-10 Admelog Sanofi-Aventis U.S. LLC47918-0874-90 Afrezza Mannkind Corporation Yes47918-0878-90 Afrezza Mannkind Corporation Yes47918-0880-18 Afrezza Mannkind Corporation Yes47918-0882-36 Afrezza Mannkind Corporation Yes47918-0884-63 Afrezza MannKind Corporation Yes47918-0891-90 Afrezza Mannkind Corporation Yes47918-0894-63 Afrezza Mannkind Corporation Yes47918-0902-18 Afrezza Mannkind Corporation Yes45802-0169-72 Alogliptin-Metformin Perrigo New York Inc45802-0211-72 Alogliptin-Metformin Perrigo New York Inc00039-0221-10 Amaryl Sanofi-Aventis U.S. LLC00088-2500-33 Apidra Sanofi-Aventis U.S. LLC Yes00088-2502-05 Apidra Sanofi-Aventis U.S. LLC Yes00173-0861-18 Avandia GlaxoSmithKline LLC00002-7715-01 Basaglar Eli Lilly and Company00002-7715-59 Basaglar Eli Lilly and Company

Page 9: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 2 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

60687-0286-21 Bromocriptine American Health Packaging00378-2042-01 Bromocriptine Mylan00378-7096-01 Bromocriptine Mylan00378-7096-93 Bromocriptine Mylan00574-0106-01 Bromocriptine Paddock Laboratories, LLC00574-0106-03 Bromocriptine Paddock Laboratories, LLC00781-5325-01 Bromocriptine Sandoz Inc00781-5325-31 Bromocriptine Sandoz Inc63304-0962-30 Bromocriptine Sun Pharmaceutical Industries, Inc.68382-0110-06 Bromocriptine Zydus Pharmaceuticals (USA) Inc.00310-6520-04 Bydureon AstraZeneca Pharmaceuticals LP00310-6530-04 Bydureon AstraZeneca Pharmaceuticals LP00310-6540-04 Bydureon BCise AstraZeneca Pharmaceuticals LP00310-6512-01 Byetta AstraZeneca Pharmaceuticals LP00310-6524-01 Byetta AstraZeneca Pharmaceuticals LP51660-0996-28 Colesevelam Ohm Laboratories, Inc.68012-0258-20 Cycloset Santarus, Inc. Yes00003-1428-11 Farxiga AstraZeneca Pharmaceuticals LP00310-6205-30 Farxiga AstraZeneca Pharmaceuticals LP Yes00310-6210-30 Farxiga AstraZeneca Pharmaceuticals LP Yes00169-3201-11 Fiasp Novo Nordisk Yes00169-3204-15 Fiasp Novo Nordisk Yes59630-0574-60 Fortamet ER Shionogi Inc.59630-0575-60 Fortamet ER Shionogi Inc.16729-0001-01 Glimepiride Accord Healthcare Inc Yes16729-0001-16 Glimepiride Accord Healthcare Inc Yes16729-0002-01 Glimepiride Accord Healthcare Inc Yes16729-0002-16 Glimepiride Accord Healthcare Inc Yes16729-0003-01 Glimepiride Accord Healthcare Inc Yes16729-0003-16 Glimepiride Accord Healthcare Inc Yes69452-0128-20 Glimepiride Bionpharma Inc.69452-0128-30 Glimepiride Bionpharma Inc.69452-0129-20 Glimepiride Bionpharma Inc.69452-0130-20 Glimepiride Bionpharma Inc.69452-0130-30 Glimepiride Bionpharma Inc.68001-0177-00 Glimepiride BluePoint Laboratories68001-0178-00 Glimepiride BluePoint Laboratories68001-0178-03 Glimepiride BluePoint Laboratories68001-0179-00 Glimepiride BluePoint Laboratories68001-0179-03 Glimepiride BluePoint Laboratories61442-0115-01 Glimepiride Carlsbad Technology, Inc.61442-0116-01 Glimepiride Carlsbad Technology, Inc.61442-0116-05 Glimepiride Carlsbad Technology, Inc.61442-0117-01 Glimepiride Carlsbad Technology, Inc.

9

Page 10: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 3 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

61442-0117-05 Glimepiride Carlsbad Technology, Inc.55111-0320-01 Glimepiride Dr. Reddy's Laboratories Limited55111-0320-05 Glimepiride Dr. Reddy's Laboratories Limited55111-0321-01 Glimepiride Dr. Reddy's Laboratories Limited55111-0321-05 Glimepiride Dr. Reddy's Laboratories Limited55111-0322-01 Glimepiride Dr. Reddy's Laboratories Limited55111-0322-05 Glimepiride Dr. Reddy's Laboratories Limited54458-0966-10 Glimepiride International Laboratories, LLC54458-0966-16 Glimepiride International Laboratories, LLC54458-0967-10 Glimepiride International Laboratories, LLC54458-0967-16 Glimepiride International Laboratories, LLC54458-0968-10 Glimepiride International Laboratories, LLC68645-0572-90 Glimepiride Legacy Pharmaceutical Packaging, LLC68645-0573-90 Glimepiride Legacy Pharmaceutical Packaging, LLC51079-0426-20 Glimepiride Mylan00378-4012-01 Glimepiride Mylan00378-4013-01 Glimepiride Mylan00093-7254-01 Glimepiride Teva Pharmaceuticals USA, Inc.00093-7255-01 Glimepiride Teva Pharmaceuticals USA, Inc.00093-7256-01 Glimepiride Teva Pharmaceuticals USA, Inc.00093-7256-52 Glimepiride Teva Pharmaceuticals USA, Inc.69543-0123-10 Glimepiride Virtus Pharmaceuticals69543-0123-50 Glimepiride Virtus Pharmaceuticals69543-0124-10 Glimepiride Virtus Pharmaceuticals69543-0124-50 Glimepiride Virtus Pharmaceuticals69543-0125-10 Glimepiride Virtus Pharmaceuticals69543-0125-50 Glimepiride Virtus Pharmaceuticals16729-0139-00 Glipizide Accord Healthcare Inc.16729-0139-16 Glipizide Accord Healthcare Inc.16729-0140-00 Glipizide Accord Healthcare Inc.16729-0140-16 Glipizide Accord Healthcare Inc.00591-0460-01 Glipizide Actavis Pharma, Inc.00591-0460-05 Glipizide Actavis Pharma, Inc.00591-0460-10 Glipizide Actavis Pharma, Inc.00591-0461-01 Glipizide Actavis Pharma, Inc.00591-0461-05 Glipizide Actavis Pharma, Inc.00591-0461-10 Glipizide Actavis Pharma, Inc.60505-0141-00 Glipizide Apotex Corp.60505-0141-01 Glipizide Apotex Corp.60505-0141-02 Glipizide Apotex Corp.60505-0142-00 Glipizide Apotex Corp.60505-0142-01 Glipizide Apotex Corp.60505-0142-02 Glipizide Apotex Corp.60505-0142-04 Glipizide Apotex Corp.

10

Page 11: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 4 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

68645-0150-54 Glipizide Legacy Pharmaceutical Packaging, LLC68645-0151-59 Glipizide Legacy Pharmaceutical Packaging, LLC51079-0810-20 Glipizide Mylan51079-0811-20 Glipizide Mylan00378-1105-01 Glipizide Mylan00378-1105-05 Glipizide Mylan00378-1110-01 Glipizide Mylan00378-1110-05 Glipizide Mylan00781-1452-01 Glipizide Sandoz Inc00781-1452-10 Glipizide Sandoz Inc00781-1453-01 Glipizide Sandoz Inc00781-1453-10 Glipizide Sandoz Inc57664-0398-13 Glipizide Sun Pharmaceutical Industries, Inc.00591-0844-01 Glipizide ER Actavis Pharma, Inc.00591-0844-10 Glipizide ER Actavis Pharma, Inc.00591-0844-15 Glipizide ER Actavis Pharma, Inc.00591-0845-01 Glipizide ER Actavis Pharma, Inc.00591-0845-10 Glipizide ER Actavis Pharma, Inc.00591-0845-15 Glipizide ER Actavis Pharma, Inc.00591-0900-30 Glipizide ER Actavis Pharma, Inc.68084-0111-01 Glipizide ER American Health Packaging Yes68084-0112-01 Glipizide ER American Health Packaging Yes68084-0295-21 Glipizide ER American Health Packaging Yes00378-0340-93 Glipizide ER Mylan00378-0342-01 Glipizide ER Mylan00378-0431-01 Glipizide ER Mylan10370-0745-01 Glipizide ER Par Pharmaceutical, Inc.10370-0745-05 Glipizide ER Par Pharmaceutical, Inc.10370-0746-01 Glipizide ER Par Pharmaceutical, Inc.10370-0746-05 Glipizide ER Par Pharmaceutical, Inc.10370-0190-01 Glipizide ER Par Pharmaceuticals, Inc.10370-0190-05 Glipizide ER Par Pharmaceuticals, Inc.10370-0191-01 Glipizide ER Par Pharmaceuticals, Inc.10370-0191-05 Glipizide ER Par Pharmaceuticals, Inc.64980-0279-03 Glipizide ER Rising Pharmaceuticals, Inc.64980-0280-01 Glipizide ER Rising Pharmaceuticals, Inc.64980-0280-05 Glipizide ER Rising Pharmaceuticals, Inc.64980-0281-01 Glipizide ER Rising Pharmaceuticals, Inc.64980-0281-05 Glipizide ER Rising Pharmaceuticals, Inc.59762-0540-01 Glipizide XL Greenstone LLC59762-0541-01 Glipizide XL Greenstone LLC59762-0541-02 Glipizide XL Greenstone LLC59762-0542-01 Glipizide XL Greenstone LLC59762-0542-02 Glipizide XL Greenstone LLC

11

Page 12: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 5 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

23155-0116-01 Glipizide-Metformin Heritage Pharmaceuticals Inc.23155-0117-01 Glipizide-Metformin Heritage Pharmaceuticals Inc.00378-3132-01 Glipizide-Metformin Mylan00378-3133-01 Glipizide-Metformin Mylan00093-7455-01 Glipizide-Metformin Teva Pharmaceuticals USA, Inc.00093-7456-01 Glipizide-Metformin Teva Pharmaceuticals USA, Inc.00093-7457-01 Glipizide-Metformin Teva Pharmaceuticals USA, Inc.68382-0185-01 Glipizide-Metformin Zydus Pharmaceuticals (USA) Inc.68382-0186-01 Glipizide-Metformin Zydus Pharmaceuticals (USA) Inc.00169-7065-15 Glucagen Novo Nordisk Yes00002-8031-01 Glucagon Eli Lilly and Company Yes00087-6060-05 Glucophage Bristol-Myers Squibb Company00087-6071-11 Glucophage Bristol-Myers Squibb Company00087-6064-13 Glucophage XR Bristol-Myers Squibb Company00049-4110-66 Glucotrol Roerig Yes00049-4120-66 Glucotrol Roerig Yes00049-0170-01 Glucotrol XL Roerig Yes00049-0174-02 Glucotrol XL Roerig Yes00049-0174-03 Glucotrol XL Roerig Yes00049-0178-07 Glucotrol XL Roerig Yes00049-0178-08 Glucotrol XL Roerig Yes68012-0002-13 Glumetza ER Santarus, Inc.68012-0003-16 Glumetza ER Santarus, Inc.65862-0028-01 Glyburide Aurobindo Pharma Limited65862-0029-01 Glyburide Aurobindo Pharma Limited65862-0030-01 Glyburide Aurobindo Pharma Limited65862-0030-99 Glyburide Aurobindo Pharma Limited57237-0022-05 Glyburide Citron Pharma LLC23155-0056-01 Glyburide Heritage Pharmaceuticals Inc.23155-0057-01 Glyburide Heritage Pharmaceuticals Inc.23155-0058-01 Glyburide Heritage Pharmaceuticals Inc.23155-0058-10 Glyburide Heritage Pharmaceuticals Inc.63739-0119-10 Glyburide McKesson Corporation51079-0872-20 Glyburide Mylan51079-0873-20 Glyburide Mylan00093-9364-01 Glyburide TEVA Pharmaceuticals USA Inc00093-9364-05 Glyburide TEVA Pharmaceuticals USA Inc00093-9364-10 Glyburide TEVA Pharmaceuticals USA Inc00093-9433-01 Glyburide TEVA Pharmaceuticals USA Inc00093-9433-05 Glyburide TEVA Pharmaceuticals USA Inc00093-9477-53 Glyburide TEVA Pharmaceuticals USA Inc00093-8342-01 Glyburide Teva Pharmaceuticals USA, Inc.00093-8343-01 Glyburide Teva Pharmaceuticals USA, Inc.00093-8343-05 Glyburide Teva Pharmaceuticals USA, Inc.

12

Page 13: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 6 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00093-8343-10 Glyburide Teva Pharmaceuticals USA, Inc.00093-8343-98 Glyburide Teva Pharmaceuticals USA, Inc.00093-8344-01 Glyburide Teva Pharmaceuticals USA, Inc.00093-8344-05 Glyburide Teva Pharmaceuticals USA, Inc.00093-8344-10 Glyburide Teva Pharmaceuticals USA, Inc.00093-8344-98 Glyburide Teva Pharmaceuticals USA, Inc.52817-0120-10 Glyburide TruPharma, LLC52817-0121-10 Glyburide TruPharma, LLC52817-0122-00 Glyburide TruPharma, LLC52817-0122-10 Glyburide TruPharma, LLC68382-0657-01 Glyburide Zydus Pharmaceuticals (USA) Inc.68382-0658-10 Glyburide Zydus Pharmaceuticals (USA) Inc.00378-1125-10 Glyburide Micro Mylan00093-8034-01 Glyburide Micro Teva Pharmaceuticals USA, Inc.00093-8035-01 Glyburide Micro Teva Pharmaceuticals USA, Inc.00093-8035-05 Glyburide Micro Teva Pharmaceuticals USA, Inc.00093-8036-01 Glyburide Micro Teva Pharmaceuticals USA, Inc.00143-9918-01 Glyburide Micro West-Ward Pharmaceuticals Corp00143-9919-01 Glyburide Micro West-Ward Pharmaceuticals Corp00143-9920-01 Glyburide Micro West-Ward Pharmaceuticals Corp00143-9920-05 Glyburide Micro West-Ward Pharmaceuticals Corp00228-2752-11 Glyburide-Metformin Actavis Pharma, Inc.00228-2753-11 Glyburide-Metformin Actavis Pharma, Inc.65862-0081-01 Glyburide-Metformin Aurobindo Pharma Limited65862-0082-01 Glyburide-Metformin Aurobindo Pharma Limited65862-0082-05 Glyburide-Metformin Aurobindo Pharma Limited57237-0024-01 Glyburide-Metformin Rising Health, LLC57237-0024-05 Glyburide-Metformin Rising Health, LLC57237-0025-01 Glyburide-Metformin Rising Health, LLC57237-0025-05 Glyburide-Metformin Rising Health, LLC00093-5712-05 Glyburide-Metformin Teva Pharmaceuticals USA, Inc.68382-0654-05 Glyburide-Metformin Zydus Pharmaceuticals (USA) Inc.68382-0655-05 Glyburide-Metformin Zydus Pharmaceuticals (USA) Inc.65862-0080-01 Glyburid-Metformin Aurobindo Pharma Limited57237-0023-01 Glyburid-Metformin Rising Health, LLC00009-0341-01 Glynase Pharmacia and Upjohn Company LLC Yes00009-5012-01 Glyset Pharmacia and Upjohn Company LLC Yes00009-5013-01 Glyset Pharmacia and Upjohn Company LLC Yes00009-5014-01 Glyset Pharmacia and Upjohn Company LLC Yes54868-4203-00 Glyset Physicians Total Care, Inc.00597-0164-30 Glyxambi Boehringer Ingelheim Pharmaceuticals, Inc.00597-0164-39 Glyxambi Boehringer Ingelheim Pharmaceuticals, Inc.00597-0164-90 Glyxambi Boehringer Ingelheim Pharmaceuticals, Inc.00597-0182-30 Glyxambi Boehringer Ingelheim Pharmaceuticals, Inc.

13

Page 14: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 7 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00597-0182-39 Glyxambi Boehringer Ingelheim Pharmaceuticals, Inc.00597-0182-90 Glyxambi Boehringer Ingelheim Pharmaceuticals, Inc.00002-7510-01 Humalog Eli Lilly and Company00002-7510-17 Humalog Eli Lilly and Company00002-7516-59 Humalog Eli Lilly and Company00002-7712-01 Humalog Eli Lilly and Company00002-7712-27 Humalog Eli Lilly and Company00002-8799-01 Humalog Eli Lilly and Company00002-8799-59 Humalog Eli Lilly and Company00002-7512-01 Humalog 50-50 Eli Lilly and Company00002-8798-01 Humalog 50-50 Eli Lilly and Company00002-8798-59 Humalog 50-50 Eli Lilly and Company00002-7511-01 Humalog 75-25 Eli Lilly and Company00002-8797-59 Humalog 75-25 Eli Lilly and Company00002-7714-59 Humalog Jr Eli Lilly and Company00002-8715-01 Humulin 70/30 Eli Lilly and Company00002-8715-17 Humulin 70/30 Eli Lilly and Company00002-8803-01 Humulin 70/30 Eli Lilly and Company00002-8803-59 Humulin 70/30 Eli Lilly and Company00002-8315-01 Humulin N Eli Lilly and Company00002-8315-17 Humulin N Eli Lilly and Company00002-8805-59 Humulin N Eli Lilly and Company00002-8215-01 Humulin R Eli Lilly and Company00002-8215-17 Humulin R Eli Lilly and Company00002-8501-01 Humulin R500 Eli Lilly and Company00002-8824-27 Humulin R500 Eli Lilly and Company50458-0540-60 Invokamet Janssen Pharmaceuticals, Inc. Yes50458-0541-60 Invokamet Janssen Pharmaceuticals, Inc. Yes50458-0542-60 Invokamet Janssen Pharmaceuticals, Inc. Yes50458-0543-60 Invokamet Janssen Pharmaceuticals, Inc. Yes50458-0940-01 Invokamet XR Janssen Pharmaceuticals, Inc. Yes50458-0941-01 Invokamet XR Janssen Pharmaceuticals, Inc. Yes50458-0942-01 Invokamet XR Janssen Pharmaceuticals, Inc. Yes50458-0943-01 Invokamet XR Janssen Pharmaceuticals, Inc. Yes50458-0140-30 Invokana Janssen Pharmaceuticals, Inc. Yes50458-0140-90 Invokana Janssen Pharmaceuticals, Inc. Yes50458-0141-30 Invokana Janssen Pharmaceuticals, Inc. Yes50458-0141-90 Invokana Janssen Pharmaceuticals, Inc. Yes00006-0575-61 Janumet Merck Sharp & Dohme Corp. Yes00006-0575-62 Janumet Merck Sharp & Dohme Corp. Yes00006-0575-82 Janumet Merck Sharp & Dohme Corp. Yes00006-0577-61 Janumet Merck Sharp & Dohme Corp. Yes00006-0577-62 Janumet Merck Sharp & Dohme Corp. Yes00006-0577-82 Janumet Merck Sharp & Dohme Corp. Yes

14

Page 15: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 8 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00006-0078-61 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0078-62 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0080-61 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0080-62 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0080-82 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0081-31 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0081-54 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0081-82 Janumet XR Merck Sharp & Dohme Corp. Yes00006-0112-28 Januvia Merck Sharp & Dohme Corp. Yes00006-0112-31 Januvia Merck Sharp & Dohme Corp. Yes00006-0112-54 Januvia Merck Sharp & Dohme Corp. Yes00006-0221-28 Januvia Merck Sharp & Dohme Corp. Yes00006-0221-31 Januvia Merck Sharp & Dohme Corp. Yes00006-0221-54 Januvia Merck Sharp & Dohme Corp. Yes00006-0277-01 Januvia Merck Sharp & Dohme Corp.00006-0277-02 Januvia Merck Sharp & Dohme Corp. Yes00006-0277-28 Januvia Merck Sharp & Dohme Corp. Yes00006-0277-31 Januvia Merck Sharp & Dohme Corp. Yes00006-0277-33 Januvia Merck Sharp & Dohme Corp. Yes00006-0277-54 Januvia Merck Sharp & Dohme Corp. Yes00006-0277-82 Januvia Merck Sharp & Dohme Corp. Yes00597-0152-30 Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0152-37 Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0152-90 Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0153-30 Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0153-37 Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0153-90 Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0146-18 Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0146-60 Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0147-18 Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0147-60 Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0148-18 Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0148-60 Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0270-73 Jentadueto XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0270-94 Jentadueto XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0275-33 Jentadueto XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0275-81 Jentadueto XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes64764-0335-60 Kazano Takeda Pharmaceuticals U.S.A., Inc.64764-0337-60 Kazano Takeda Pharmaceuticals U.S.A., Inc.00310-6125-60 Kombiglyze XR AstraZeneca Pharmaceuticals LP00310-6135-30 Kombiglyze XR AstraZeneca Pharmaceuticals LP00310-6145-30 Kombiglyze XR AstraZeneca Pharmaceuticals LP00088-2219-05 Lantus sanofi-aventis U.S. LLC Yes00088-2220-33 Lantus sanofi-aventis U.S. LLC Yes

15

Page 16: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 9 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00088-5020-05 Lantus sanofi-aventis U.S. LLC Yes00088-5021-01 Lantus sanofi-aventis U.S. LLC Yes00169-3687-12 Levemir Novo Nordisk Yes00169-6438-10 Levemir Novo Nordisk Yes00591-2412-19 Metformin Actavis Pharma, Inc.00591-2719-60 Metformin Actavis Pharma, Inc.62037-0571-01 Metformin Actavis Pharma, Inc.62037-0571-10 Metformin Actavis Pharma, Inc.62037-0577-01 Metformin Actavis Pharma, Inc.60687-0143-01 Metformin American Health Packaging Yes65162-0220-10 Metformin Amneal Pharmaceuticals LLC65162-0220-11 Metformin Amneal Pharmaceuticals LLC65162-0220-50 Metformin Amneal Pharmaceuticals LLC53746-0178-01 Metformin Amneal Pharmaceuticals of New York LLC53746-0178-05 Metformin Amneal Pharmaceuticals of New York LLC53746-0178-10 Metformin Amneal Pharmaceuticals of New York LLC53746-0178-90 Metformin Amneal Pharmaceuticals of New York LLC53746-0179-01 Metformin Amneal Pharmaceuticals of New York LLC53746-0218-01 Metformin Amneal Pharmaceuticals of New York LLC53746-0218-05 Metformin Amneal Pharmaceuticals of New York LLC53746-0218-10 Metformin Amneal Pharmaceuticals of New York LLC53746-0219-01 Metformin Amneal Pharmaceuticals of New York LLC53746-0219-05 Metformin Amneal Pharmaceuticals of New York LLC53746-0219-10 Metformin Amneal Pharmaceuticals of New York LLC53746-0220-01 Metformin Amneal Pharmaceuticals of New York LLC53746-0220-05 Metformin Amneal Pharmaceuticals of New York LLC53746-0220-10 Metformin Amneal Pharmaceuticals of New York LLC60505-0190-00 Metformin Apotex Corp.60505-0260-01 Metformin Apotex Corp.60505-0260-02 Metformin Apotex Corp.60505-1329-01 Metformin Apotex Corp.67877-0159-01 Metformin Ascend Laboratories, LLC67877-0159-05 Metformin Ascend Laboratories, LLC67877-0159-10 Metformin Ascend Laboratories, LLC67877-0217-05 Metformin Ascend Laboratories, LLC67877-0217-10 Metformin Ascend Laboratories, LLC67877-0221-01 Metformin Ascend Laboratories, LLC67877-0221-05 Metformin Ascend Laboratories, LLC67877-0221-10 Metformin Ascend Laboratories, LLC67877-0561-01 Metformin Ascend Laboratories, LLC67877-0561-05 Metformin Ascend Laboratories, LLC67877-0561-10 Metformin Ascend Laboratories, LLC67877-0562-05 Metformin Ascend Laboratories, LLC67877-0562-10 Metformin Ascend Laboratories, LLC

16

Page 17: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 10 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

67877-0563-01 Metformin Ascend Laboratories, LLC67877-0563-05 Metformin Ascend Laboratories, LLC67877-0563-10 Metformin Ascend Laboratories, LLC65862-0008-01 Metformin Aurobindo Pharma Limited65862-0008-05 Metformin Aurobindo Pharma Limited65862-0008-99 Metformin Aurobindo Pharma Limited65862-0009-01 Metformin Aurobindo Pharma Limited65862-0009-05 Metformin Aurobindo Pharma Limited65862-0010-01 Metformin Aurobindo Pharma Limited65862-0010-05 Metformin Aurobindo Pharma Limited65862-0010-99 Metformin Aurobindo Pharma Limited00185-4416-01 Metformin Eon Labs, Inc.42806-0213-05 Metformin Epic Pharma, LLC42806-0213-10 Metformin Epic Pharma, LLC42806-0215-01 Metformin Epic Pharma, LLC42806-0221-05 Metformin Epic Pharma, LLC42806-0313-05 Metformin Epic Pharma, LLC42806-0314-01 Metformin Epic Pharma, LLC42806-0315-05 Metformin Epic Pharma, LLC68462-0159-01 Metformin Glenmark Pharmaceuticals Inc., USA68462-0159-05 Metformin Glenmark Pharmaceuticals Inc., USA68462-0159-10 Metformin Glenmark Pharmaceuticals Inc., USA68462-0160-01 Metformin Glenmark Pharmaceuticals Inc., USA68462-0161-05 Metformin Glenmark Pharmaceuticals Inc., USA23155-0102-01 Metformin Heritage Pharmaceuticals Inc.23155-0102-05 Metformin Heritage Pharmaceuticals Inc.23155-0102-10 Metformin Heritage Pharmaceuticals Inc.23155-0103-01 Metformin Heritage Pharmaceuticals Inc.23155-0103-05 Metformin Heritage Pharmaceuticals Inc.23155-0103-10 Metformin Heritage Pharmaceuticals Inc.23155-0104-01 Metformin Heritage Pharmaceuticals Inc.23155-0104-05 Metformin Heritage Pharmaceuticals Inc.23155-0104-10 Metformin Heritage Pharmaceuticals Inc.50742-0154-01 Metformin Ingenus Pharmaceuticals, LLC50742-0154-05 Metformin Ingenus Pharmaceuticals, LLC50742-0154-10 Metformin Ingenus Pharmaceuticals, LLC50742-0154-90 Metformin Ingenus Pharmaceuticals, LLC50742-0155-01 Metformin Ingenus Pharmaceuticals, LLC50742-0155-05 Metformin Ingenus Pharmaceuticals, LLC50742-0155-10 Metformin Ingenus Pharmaceuticals, LLC50742-0156-05 Metformin Ingenus Pharmaceuticals, LLC50742-0156-10 Metformin Ingenus Pharmaceuticals, LLC68645-0300-59 Metformin Legacy Pharmaceutical Packaging, LLC68645-0539-59 Metformin Legacy Pharmaceutical Packaging, LLC

17

Page 18: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 11 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

68645-0544-59 Metformin Legacy Pharmaceutical Packaging, LLC68645-0545-59 Metformin Legacy Pharmaceutical Packaging, LLC68645-0546-59 Metformin Legacy Pharmaceutical Packaging, LLC68645-0547-59 Metformin Legacy Pharmaceutical Packaging, LLC68645-0549-59 Metformin Legacy Pharmaceutical Packaging, LLC68180-0336-07 Metformin Lupin Pharmaceuticals, Inc.68180-0338-01 Metformin Lupin Pharmaceuticals, Inc.68180-0339-09 Metformin Lupin Pharmaceuticals, Inc.33342-0240-11 Metformin Macleods Pharmaceuticals Limited00904-6326-61 Metformin Major Pharmaceuticals38779-2126-05 Metformin Medisca, Inc.58657-0640-10 Metformin Method Pharmaceuticals, LLC00378-6002-91 Metformin Mylan00378-7185-05 Metformin Mylan00378-7186-05 Metformin Mylan00378-7187-05 Metformin Mylan68682-0017-10 Metformin Oceanside Pharmaceuticals68682-0018-90 Metformin Oceanside Pharmaceuticals51927-3105-00 Metformin Professional Co.00781-5503-01 Metformin SANDOZ INC.43547-0248-50 Metformin Solco healthcare U.S., LLC43547-0249-50 Metformin Solco healthcare U.S., LLC43547-0357-10 Metformin Solco healthcare U.S., LLC43547-0357-11 Metformin Solco healthcare U.S., LLC43547-0357-50 Metformin Solco healthcare U.S., LLC43547-0358-50 Metformin Solco healthcare U.S., LLC43547-0359-10 Metformin Solco healthcare U.S., LLC43547-0359-50 Metformin Solco healthcare U.S., LLC57664-0397-51 Metformin Sun Pharmaceutical Industries, Inc.57664-0397-53 Metformin Sun Pharmaceutical Industries, Inc.57664-0397-58 Metformin Sun Pharmaceutical Industries, Inc.57664-0435-51 Metformin Sun Pharmaceutical Industries, Inc.57664-0435-53 Metformin Sun Pharmaceutical Industries, Inc.57664-0435-58 Metformin Sun Pharmaceutical Industries, Inc.57664-0435-88 Metformin Sun Pharmaceutical Industries, Inc.57664-0474-51 Metformin Sun Pharmaceutical Industries, Inc.57664-0474-53 Metformin Sun Pharmaceutical Industries, Inc.57664-0474-58 Metformin Sun Pharmaceutical Industries, Inc.57664-0474-88 Metformin Sun Pharmaceutical Industries, Inc.62756-0142-01 Metformin Sun Pharmaceutical Industries, Inc.62756-0142-02 Metformin Sun Pharmaceutical Industries, Inc.62756-0143-01 Metformin Sun Pharmaceutical Industries, Inc.51224-0007-50 Metformin TAGI Pharma, Inc.51224-0007-60 Metformin TAGI Pharma, Inc.

18

Page 19: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 12 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

51224-0107-50 Metformin TAGI Pharma, Inc.51224-0107-60 Metformin TAGI Pharma, Inc.00093-1048-01 Metformin Teva Pharmaceuticals USA, Inc.00093-1048-10 Metformin Teva Pharmaceuticals USA, Inc.00093-1049-10 Metformin Teva Pharmaceuticals USA, Inc.00093-7212-01 Metformin Teva Pharmaceuticals USA, Inc.00093-7214-01 Metformin Teva Pharmaceuticals USA, Inc.00093-7214-10 Metformin Teva Pharmaceuticals USA, Inc.00093-7267-01 Metformin Teva Pharmaceuticals USA, Inc.00093-7267-10 Metformin Teva Pharmaceuticals USA, Inc.49483-0620-10 Metformin TIME CAP LABORATORIES, INC49483-0621-10 Metformin TIME CAP LABORATORIES, INC49483-0623-01 Metformin TIME CAP LABORATORIES, INC Yes49483-0623-09 Metformin TIME CAP LABORATORIES, INC49483-0623-10 Metformin TIME CAP LABORATORIES, INC49483-0623-50 Metformin TIME CAP LABORATORIES, INC Yes49483-0624-01 Metformin TIME CAP LABORATORIES, INC68382-0028-10 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0030-01 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0030-05 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0030-10 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0758-01 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0758-05 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0758-10 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0759-01 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0759-05 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0759-10 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0760-01 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0760-05 Metformin Zydus Pharmaceuticals (USA) Inc.68382-0760-10 Metformin Zydus Pharmaceuticals (USA) Inc.00591-2720-60 Metformin ER Actavis Pharma, Inc.68180-0337-07 Metformin ER Lupin Pharmaceuticals, Inc.00378-6001-91 Metformin ER Mylan29033-0032-06 Metformin ER Nostrum Laboratories, Inc.57664-0684-88 Miglitol Sun Pharmaceutical Industries Ltd.57664-0685-88 Miglitol Sun Pharmaceutical Industries Ltd.57664-0686-88 Miglitol Sun Pharmaceutical Industries Ltd.00591-3354-01 Nateglinide Actavis Pharma, Inc.00591-3355-01 Nateglinide Actavis Pharma, Inc.68084-0458-21 Nateglinide American Health Packaging68084-0459-21 Nateglinide American Health Packaging55111-0328-90 Nateglinide Dr. Reddy's Laboratories Limited55111-0329-90 Nateglinide Dr. Reddy's Laboratories Limited49884-0984-01 Nateglinide Par Pharmaceutical, Inc.

19

Page 20: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 13 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

49884-0985-01 Nateglinide Par Pharmaceutical, Inc.68382-0721-16 Nateglinide Zydus Pharmaceuticals (USA) Inc.68382-0722-16 Nateglinide Zydus Pharmaceuticals (USA) Inc.64764-0125-30 Nesina Takeda Pharmaceuticals U.S.A., Inc.64764-0250-30 Nesina Takeda Pharmaceuticals U.S.A., Inc.64764-0625-30 Nesina Takeda Pharmaceuticals U.S.A., Inc.00169-1837-02 Novolin 70-30 Novo Nordisk00169-1837-11 Novolin 70-30 Novo Nordisk00169-1834-02 Novolin N Novo Nordisk00169-1834-11 Novolin N Novo Nordisk00169-1833-02 Novolin R Novo Nordisk00169-1833-11 Novolin R Novo Nordisk00169-3303-12 Novolog Novo Nordisk Yes00169-6339-10 Novolog Novo Nordisk Yes00169-7501-11 Novolog Novo Nordisk Yes32849-0500-81 Novolog Novo Nordisk00169-3685-12 Novolog 70/30 Novo Nordisk Yes00169-3696-19 Novolog 70/30 Novo Nordisk Yes00310-6100-30 Onglyza AstraZeneca Pharmaceuticals LP00310-6100-90 Onglyza AstraZeneca Pharmaceuticals LP00310-6105-30 Onglyza AstraZeneca Pharmaceuticals LP00310-6105-50 Onglyza AstraZeneca Pharmaceuticals LP00310-6105-90 Onglyza AstraZeneca Pharmaceuticals LP64764-0121-03 Oseni Takeda Pharmaceuticals U.S.A., Inc.64764-0251-03 Oseni Takeda Pharmaceuticals U.S.A., Inc.64764-0253-03 Oseni Takeda Pharmaceuticals U.S.A., Inc.00169-4132-12 Ozempic Novo Nordisk Yes00169-4136-02 Ozempic Novo Nordisk Yes16729-0020-10 Pioglitazone Accord Healthcare, Inc.16729-0020-15 Pioglitazone Accord Healthcare, Inc.16729-0020-16 Pioglitazone Accord Healthcare, Inc.16729-0021-10 Pioglitazone Accord Healthcare, Inc.16729-0021-15 Pioglitazone Accord Healthcare, Inc.16729-0021-16 Pioglitazone Accord Healthcare, Inc.16729-0022-10 Pioglitazone Accord Healthcare, Inc.16729-0022-15 Pioglitazone Accord Healthcare, Inc.16729-0022-16 Pioglitazone Accord Healthcare, Inc.00591-3205-05 Pioglitazone Actavis Pharma, Inc.00591-3205-19 Pioglitazone Actavis Pharma, Inc.00591-3205-30 Pioglitazone Actavis Pharma, Inc.00591-3206-19 Pioglitazone Actavis Pharma, Inc.00591-3206-30 Pioglitazone Actavis Pharma, Inc.00591-3207-05 Pioglitazone Actavis Pharma, Inc.00591-3207-19 Pioglitazone Actavis Pharma, Inc.

20

Page 21: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 14 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00591-3207-30 Pioglitazone Actavis Pharma, Inc.68084-0878-01 Pioglitazone American Health Packaging54458-0864-10 Pioglitazone International Laboratories, LLC Yes54458-0865-10 Pioglitazone International Laboratories, LLC Yes54458-0866-10 Pioglitazone International Laboratories, LLC Yes33342-0054-07 Pioglitazone Macleods Pharmaceuticals Limited33342-0054-10 Pioglitazone Macleods Pharmaceuticals Limited33342-0054-15 Pioglitazone Macleods Pharmaceuticals Limited33342-0055-07 Pioglitazone Macleods Pharmaceuticals Limited33342-0055-10 Pioglitazone Macleods Pharmaceuticals Limited33342-0055-15 Pioglitazone Macleods Pharmaceuticals Limited33342-0056-07 Pioglitazone Macleods Pharmaceuticals Limited33342-0056-10 Pioglitazone Macleods Pharmaceuticals Limited51079-0513-20 Pioglitazone Mylan00378-0048-77 Pioglitazone Mylan00378-0048-93 Pioglitazone Mylan00378-0228-77 Pioglitazone Mylan00378-0228-93 Pioglitazone Mylan00378-0318-93 Pioglitazone Mylan63304-0313-30 Pioglitazone Ranbaxy Pharmaceuticals Inc.00781-5420-31 Pioglitazone Sandoz Inc00781-5420-92 Pioglitazone Sandoz Inc00781-5421-31 Pioglitazone Sandoz Inc00781-5421-92 Pioglitazone Sandoz Inc00781-5422-31 Pioglitazone Sandoz Inc00781-5422-92 Pioglitazone Sandoz Inc00093-2046-98 Pioglitazone Teva Pharmaceuticals USA Inc00093-2047-98 Pioglitazone Teva Pharmaceuticals USA Inc00093-7271-56 Pioglitazone Teva Pharmaceuticals USA, Inc.00093-7271-98 Pioglitazone Teva Pharmaceuticals USA, Inc.00093-7272-56 Pioglitazone Teva Pharmaceuticals USA, Inc.00093-7272-98 Pioglitazone Teva Pharmaceuticals USA, Inc.00093-7273-56 Pioglitazone Teva Pharmaceuticals USA, Inc.00093-7273-98 Pioglitazone Teva Pharmaceuticals USA, Inc.13668-0119-05 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0119-30 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0119-90 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0120-05 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0120-30 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0120-90 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0140-30 Pioglitazone TORRENT PHARMACEUTICALS LIMITED13668-0140-90 Pioglitazone TORRENT PHARMACEUTICALS LIMITED66993-0821-30 Pioglitazone-Glimepiride Prasco Laboratories66993-0822-30 Pioglitazone-Glimepiride Prasco Laboratories

21

Page 22: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 15 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00781-5634-31 Pioglitazone-Glimepiride Sandoz Inc00781-5635-31 Pioglitazone-Glimepiride Sandoz Inc65862-0525-60 Pioglitazone-Metformin Aurobindo Pharma Limited65862-0526-18 Pioglitazone-Metformin Aurobindo Pharma Limited65862-0526-60 Pioglitazone-Metformin Aurobindo Pharma Limited33342-0177-09 Pioglitazone-Metformin Macleods Pharmaceuticals Limited00378-1550-91 Pioglitazone-Metformin Mylan00378-1575-91 Pioglitazone-Metformin Mylan57237-0218-60 Pioglitazone-Metformin Rising Health, LLC00781-5626-60 Pioglitazone-Metformin Sandoz Inc00781-5627-60 Pioglitazone-Metformin Sandoz Inc00093-7677-06 Pioglitazone-Metformin Teva Pharmaceuticals USA, Inc.00093-7678-06 Pioglitazone-Metformin Teva Pharmaceuticals USA, Inc.13668-0280-60 Pioglitazone-Metformin TORRENT PHARMACEUTICALS LIMITED13668-0281-60 Pioglitazone-Metformin TORRENT PHARMACEUTICALS LIMITED60846-0882-01 Prandin Gemini Laboratories, LLC Yes60846-0884-01 Prandin Gemini Laboratories, LLC Yes10631-0206-01 Riomet Sun Pharmaceutical Industries, Inc. Yes10631-0206-02 Riomet Sun Pharmaceutical Industries, Inc. Yes10631-0238-01 Riomet Sun Pharmaceutical Industries, Inc. Yes10631-0238-02 Riomet Sun Pharmaceutical Industries, Inc. Yes00006-5369-03 Segluromet Merck Sharp & Dohme Corp.00006-5369-06 Segluromet Merck Sharp & Dohme Corp.00006-5370-03 Segluromet Merck Sharp & Dohme Corp.00006-5370-06 Segluromet Merck Sharp & Dohme Corp.00006-5373-03 Segluromet Merck Sharp & Dohme Corp.00006-5373-06 Segluromet Merck Sharp & Dohme Corp.00006-5374-03 Segluromet Merck Sharp & Dohme Corp.00006-5374-06 Segluromet Merck Sharp & Dohme Corp.00024-5761-05 Soliqua 100/33 Sanofi-Aventis U.S. LLC Yes00078-0351-05 Starlix Novartis Pharmaceuticals Corporation Yes00078-0352-05 Starlix Novartis Pharmaceuticals Corporation Yes00006-5364-03 Steglatro Merck Sharp & Dohme Corp.00006-5364-06 Steglatro Merck Sharp & Dohme Corp.00006-5367-03 Steglujan Merck Sharp & Dohme Corp.00006-5367-06 Steglujan Merck Sharp & Dohme Corp.00006-5368-03 Steglujan Merck Sharp & Dohme Corp.00006-5368-06 Steglujan Merck Sharp & Dohme Corp.00310-6615-02 Symlinpen AstraZeneca Pharmaceuticals LP00310-6627-02 Symlinpen AstraZeneca Pharmaceuticals LP00597-0159-18 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0159-60 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0168-18 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0168-60 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes

22

Page 23: 2019 Essential Diabetes Drug List - Nevada...(Added to NRS by 2017, 4297) The first essential diabetes drug list was published on October 31, 2017. The 2019 Essential Di-abetes Drug

Appendix 2: 2019 DHHS Essential Diabetes Drug NDC ListPage 16 of 16

NDCEssential Diabetes

Drug NameLabeler

Significant Price Increase

00597-0175-18 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0175-60 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0180-18 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0180-60 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0280-90 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0290-74 Synjardy Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0280-73 Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0290-59 Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0295-78 Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0295-88 Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0300-45 Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0300-93 Synjardy XR Boehringer Ingelheim Pharmaceuticals, Inc. Yes00173-0866-01 Tanzeum GlaxoSmithKline LLC00173-0866-35 Tanzeum GlaxoSmithKline LLC00173-0867-35 Tanzeum GlaxoSmithKline LLC00024-5869-03 Toujeo Sanofi-Aventis U.S. LLC Yes00024-5871-02 Toujeo Sanofi-Aventis U.S. LLC Yes00597-0140-30 Tradjenta Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0140-61 Tradjenta Boehringer Ingelheim Pharmaceuticals, Inc. Yes00597-0140-90 Tradjenta Boehringer Ingelheim Pharmaceuticals, Inc. Yes00169-2550-13 Tresiba Novo Nordisk Yes00169-2660-15 Tresiba Novo Nordisk Yes00002-1433-01 Trulicity Eli Lilly and Company00002-1433-80 Trulicity Eli Lilly and Company Yes00002-1434-01 Trulicity Eli Lilly and Company00002-1434-80 Trulicity Eli Lilly and Company Yes00169-4060-12 Victoza Novo Nordisk Yes00169-4060-13 Victoza Novo Nordisk Yes65597-0701-18 Welchol Daiichi Sankyo Inc. Yes65597-0902-30 Welchol Daiichi Sankyo Inc. Yes00310-6250-30 Xigduo XR AstraZeneca Pharmaceuticals LP Yes00310-6260-60 Xigduo XR AstraZeneca Pharmaceuticals LP Yes00310-6270-30 Xigduo XR AstraZeneca Pharmaceuticals LP Yes00310-6280-30 Xigduo XR AstraZeneca Pharmaceuticals LP Yes00169-2911-15 Xultophy 100/3.6 Novo Nordisk Yes

23